Sunlenca® (Lenacapavir): A first-in-class, long-acting HIV-1 capsid inhibitor for treating highly multidrug-resistant HIV-1 infection

Saved in:

Bibliographic Details
Main Authors:	Chunhua Ma, Junbiao Chang, Bin Yu
Format:	Article
Language:	English
Published:	Elsevier 2024-12-01
Series:	Acta Pharmaceutica Sinica B
Subjects:	Lenacapavir Capsid inhibitor HIV-1 infection HIV prevention Multidrug resistance Antiretroviral medication
Online Access:	http://www.sciencedirect.com/science/article/pii/S2211383524003290
Tags:	Add Tag No Tags, Be the first to tag this record!

Internet